The franchise that pays for everything else has a clock, and a fundamentals desk should keep an eye on it. Vertex holds CFTR-modulator IP including US10022352B2, "Modulators of ATP-binding cassette transporters" (issued July 17, 2018) — a composition-and-formulation grant (CPC A61K 31/404 and related, with C07D heterocycle classes) on the small-molecule modulators at the heart of the cystic-fibrosis business.
Why this matters to the fundamentals story: Vertex's CF dominance generates the durable cash flow that funds its bets in pain and gene therapy. That makes the CF franchise's exclusivity the financial keel of the whole company. A 2018-issued grant is a reminder that even a dominant franchise's core patents age — and the company's diversification spend is, in part, a race to build the next franchise before the current one's protection thins.
The cliff math, stated as a fundamentals input: the practical exclusivity of a multi-drug franchise is set by the stack of patents covering each approved combination, and the earliest-expiring load-bearing claim on a given regimen sets when a follow-on could enter that route. The newest combination products typically carry fresher IP than the original modulators, which is exactly why the franchise's effective cliff is later than its oldest grant suggests — but not infinite.
What the grant does not tell you: the patent-term extensions, the pediatric exclusivity, or the strength of the newer combination patents that extend the franchise beyond this older grant. Those are the records that determine the real runway, and they are not visible in a single patent title. A clean expiry call requires the whole stack, not one grant.
The earnings-and-fundamentals read: Vertex's pipeline diversification is rational precisely because the CF franchise, however durable, runs on protected molecules whose core patents have dates. Watching the CFTR-modulator IP — starting with grants like this one — is how you connect the company's R&D-spend trajectory to the franchise it is racing to replace. Durability and the cliff are the same number seen from two sides.